You must be 18 or older to view this site.
All products sold by Limitless Peptides are supplied strictly for laboratory and research use. They are not drugs, foods or cosmetics, and are not for human or veterinary consumption.
By entering you confirm you are acquiring these materials for research purposes only.
Price range: $94.00 through $154.00
Dual GIP/GLP-1 receptor agonist studied for metabolic regulation and weight management research.
Out of stock. Leave your email and we will tell you the moment it returns.
One email about this product only. You are not subscribed to anything.
First-in-class dual incretin receptor agonist combining GIP and GLP-1 activity. Studied for superior glycemic control and weight outcomes.
| Class | GIP/GLP-1 Dual Agonist |
|---|---|
| Receptor Target | GIP + GLP-1 Receptors |
| Composition | Single |
| Molecule Type | Peptide |
| Half-Life | Long-acting |
| Format | Lyophilized Powder |
| Research Area | Weight Management |
| Strength | 20 mg, 40 mg |
Growth hormone-releasing factor analogue studied for visceral fat reduction and metabolic modulation.
NNMT inhibitor studied for cellular metabolism, fat loss support, energy utilization, and body composition improvement.
Triple receptor agonist (GIP/GLP-1/glucagon) studied for advanced metabolic and weight management research.